Literature DB >> 12086930

Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes.

Vanessa van Harmelen1, Andrea Dicker, Mikael Rydén, Hans Hauner, Fredrik Lönnqvist, Erik Näslund, Peter Arner.   

Abstract

Site differences in adipose tissue function may have implications for insulin-resistant conditions. In mature adipose tissue, subcutaneous adipocytes have higher leptin secretion, similar tumor necrosis factor (TNF)-alpha secretion, and lower catecholamine-stimulated lipolysis as compared with omental adipocytes. In this study, lipolysis and leptin and TNF-alpha secretion were compared between human omental and subcutaneous preadipocytes. After 16 days of incubation in a minimal differentiation medium, leptin mRNA and secretion were found to be two to eight times higher in subcutaneous than omental preadipocytes (P < 0.05). On the other hand, norepinephrine-induced lipolysis was about two times higher in the omental than in the subcutaneous preadipocytes, whereas basal lipolysis did not differ between the two regions. TNF-alpha secretion was marginally but significantly higher in the omental than in the subcutaneous preadipocytes. Preadipocyte differentiation was equal in both regions and was augmented to the same extent by different thiazolidinediones (rosiglitazone, pioglitazone, or troglitazone) in the two depots. In the presence of rosiglitazone, leptin secretion remained about three times higher and norepinephrine-induced lipolysis about six times lower in subcutaneous as compared with omental preadipocytes (P < 0.05), whereas TNF-alpha secretion and basal lipolysis were similar in preadipocytes from the two regions. These findings remained unaltered even if rosiglitazone was removed from the medium. However, leptin mRNA showed no regional differences in rosiglitazone-treated cells. Thus, regional differences in adipocyte leptin secretion as well as in norepinephrine-induced lipolysis are marked and present during different stages of preadipocyte differentiation and seem to be determined by intrinsic (i.e., primary) factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12086930     DOI: 10.2337/diabetes.51.7.2029

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  49 in total

1.  Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter.

Authors:  Matilde Marchi; Simonetta Lisi; Michele Curcio; Serena Barbuti; Paolo Piaggi; Giovanni Ceccarini; Monica Nannipieri; Marco Anselmino; Claudio Di Salvo; Paolo Vitti; Aldo Pinchera; Ferruccio Santini; Margherita Maffei
Journal:  Epigenetics       Date:  2011-10-01       Impact factor: 4.528

2.  Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes.

Authors:  Franck Festy; Laurence Hoareau; Sandrine Bes-Houtmann; Anne-Marie Péquin; Marie-Paule Gonthier; Ashik Munstun; Jean Jacques Hoarau; Maya Césari; Régis Roche
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

3.  High plasma leptin predicts an increase in subcutaneous adiposity in children and adults.

Authors:  A Kettaneh; B Heude; M Romon; J M Oppert; J M Borys; B Balkau; P Ducimetière; M A Charles
Journal:  Eur J Clin Nutr       Date:  2006-12-13       Impact factor: 4.016

4.  Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue.

Authors:  M Kaaman; L M Sparks; V van Harmelen; S R Smith; E Sjölin; I Dahlman; P Arner
Journal:  Diabetologia       Date:  2007-09-19       Impact factor: 10.122

5.  Greater adipose tissue infiltration in skeletal muscle among older men of African ancestry.

Authors:  Iva Miljkovic; Jane A Cauley; Moira A Petit; Kristine E Ensrud; Elsa Strotmeyer; Yahtyng Sheu; Christopher L Gordon; Bret H Goodpaster; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Lewis H Kuller; Kimberly A Faulkner; Joseph M Zmuda
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

6.  Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells.

Authors:  Kerstin Schnäbele; Silvia Roser; Gerhard Rechkemmer; Hans Hauner; Thomas Skurk
Journal:  Eur J Nutr       Date:  2009-01-23       Impact factor: 5.614

7.  Does Visceral or Subcutaneous Fat Influence Peripheral Cortical Bone Strength During Adolescence? A Longitudinal Study.

Authors:  Natalie A Glass; James C Torner; Elena M Letuchy; Trudy L Burns; Kathleen F Janz; Julie M Eichenberger Gilmore; Janet A Schlechte; Steven M Levy
Journal:  J Bone Miner Res       Date:  2017-11-27       Impact factor: 6.741

8.  Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Authors:  Darcy R Barry; Kristina M Utzschneider; Jenny Tong; Kersten Gaba; Daniel F Leotta; John D Brunzell; Thomas R Easterling
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

Review 9.  Chronic inflammation in obesity and the metabolic syndrome.

Authors:  Rosário Monteiro; Isabel Azevedo
Journal:  Mediators Inflamm       Date:  2010-07-14       Impact factor: 4.711

Review 10.  Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue.

Authors:  Patricia Iozzo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.